These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38345741)
1. Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study. Freire-Alvarez E; Vanni P; Kurča E; Lopez-Manzanares L; Kovács N; Spanaki C; Gao T; Bergmann L; Sánchez-Soliño O Neurol Ther; 2024 Apr; 13(2):437-447. PubMed ID: 38345741 [TBL] [Abstract][Full Text] [Related]
2. Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial. Freire-Alvarez E; Kurča E; Lopez Manzanares L; Pekkonen E; Spanaki C; Vanni P; Liu Y; Sánchez-Soliño O; Barbato LM Mov Disord; 2021 Nov; 36(11):2615-2623. PubMed ID: 34236101 [TBL] [Abstract][Full Text] [Related]
3. Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study. Chung SJ; Calopa M; Ceravolo MG; Tambasco N; Antonini A; Chaudhuri KR; Robieson WZ; Sánchez-Soliño O; Zadikoff C; Jin M; Barbato LM Parkinsons Dis; 2022; 2022():1216975. PubMed ID: 36388237 [TBL] [Abstract][Full Text] [Related]
4. Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia. Pahwa R; Fox S; Hauser RA; Isaacson S; Lytle J; Johnson R; Llorens L; Formella AE; Tanner CM Front Neurol; 2022; 13():846126. PubMed ID: 36341088 [TBL] [Abstract][Full Text] [Related]
5. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study. Juhász A; Aschermann Z; Ács P; Janszky J; Kovács M; Makkos A; Harmat M; Tényi D; Karádi K; Komoly S; Takáts A; Tóth A; Nagy H; Klivényi P; Dibó G; Dézsi L; Zádori D; Annus Á; Vécsei L; Varannai L; Kovács N Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758 [TBL] [Abstract][Full Text] [Related]
6. A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies. Boyd JT; Zadikoff C; Benesh JA; Zamudio J; Robieson WZ; Kukreja P; Yokoyama M; Siddiqui MS Clin Park Relat Disord; 2020; 2():25-34. PubMed ID: 34316616 [TBL] [Abstract][Full Text] [Related]
7. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients. Antonini A; Fung VS; Boyd JT; Slevin JT; Hall C; Chatamra K; Eaton S; Benesh JA Mov Disord; 2016 Apr; 31(4):530-7. PubMed ID: 26817533 [TBL] [Abstract][Full Text] [Related]